Which of Your Existing Medicines — Must Stop Before Targeted Therapy
Some of the medicines you take every day can interfere with how a targeted therapy drug works — either by reducing its effect or by raising it to a level that causes side effects. Knowing which ones to declare, and how to do it, is a straightforward step you can take before treatment begins.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Not just prescription drugs — Herbal supplements, vitamins, and over-the-counter products can all affect how a targeted drug is absorbed or broken down by your body.
- Some interactions change the drug level in your blood — A few common medicines can lower your targeted drug to a level where it stops working, or raise it until side effects appear.
- A written list is more reliable than memory — Your oncologist cannot review what they do not know about. Bringing a written list to your appointment removes the risk of forgetting something in clinic.
- Do not stop medicines without being told to — Stopping a regular medicine suddenly — especially for the heart, blood pressure, or diabetes — can cause its own harm. The plan needs to come from your team.
on Panel
Survival Rate*
Treated
(800+ reviews)
Before targeted therapy starts, tell your oncologist about every medicine you take — including herbal supplements, vitamins, and over-the-counter products. Some, like St John's Wort and antacids, are known to affect how targeted drugs work. Your team will advise which to stop and when, based on the specific drug you are starting.
Why do some of your regular medicines interfere with targeted therapy?
Targeted therapy drugs are processed by your liver using specific enzyme pathways. Many common medicines — including some herbal supplements — either speed up or slow down those pathways.
If a medicine speeds them up, your targeted drug is broken down faster and may not reach the level it needs to work. If it slows them down, the drug builds up and the risk of side effects increases.
A few targeted drugs also need a certain level of stomach acid to be absorbed properly. Medicines that routinely reduce acid can limit how much of the drug your body takes in, according to NCCN and ESMO prescribing guidance.
How to review your medicines before your targeted therapy appointment
Write down everything you currently take
Include prescription medicines, over-the-counter tablets, vitamins, mineral supplements, herbal products, and traditional preparations. Include things you take only occasionally, not just daily medicines.
Note the dose and how often you take it
Your team needs this to judge whether the dose or frequency creates a meaningful interaction — not just whether a medicine appears on a list at all.
Bring the written list to your pre-treatment appointment
A written list is more reliable than describing things from memory in clinic. If you have original packaging for supplements, bring that too — ingredient lists are useful.
Tell your oncologist about anything you started recently
A medicine you added in the last few weeks is as relevant as one you have been on for years. Recent changes to dose also matter and should be mentioned.
Wait for specific instructions before stopping anything
Your team will tell you which medicines to stop, which to continue, and how much notice is needed before your first dose. The timeline depends on the medicine and the targeted drug you are starting, so do not guess.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What to include on your medicine list — a printable summary
- Every medicine prescribed by any doctor, not only your oncologist
- Over-the-counter painkillers such as ibuprofen, aspirin, or diclofenac
- Heartburn, antacid, and acid-reducing medicines, including those bought without a prescription
- St John's Wort — one of the strongest known reducers of targeted drug levels in the blood
- Any other herbal supplement, whether bought from a pharmacy or a practitioner
- Ayurvedic, Unani, homeopathic, or other traditional preparations, including anything applied to the skin
- Vitamins and mineral supplements, especially those taken in doses above a standard daily amount
- Grapefruit and grapefruit juice — these affect the same liver enzymes as several targeted drugs
- Any medicine you take only occasionally, such as for pain, sleep, anxiety, or allergies
- Medicines from a cardiologist, neurologist, or any other specialist who is not your oncologist
Is it safe to stop a medicine yourself if you think it might clash?
No. Stopping a medicine on your own — even one your team will ultimately ask you to pause — can cause its own harm. Blood pressure medicines, diabetes medicines, antidepressants, and blood thinners all need a careful, supervised plan.
If you see a concern on any list online and feel anxious about it, call your care team rather than acting on it yourself. They can tell you, for your specific targeted drug, which interactions matter and which do not.
The same applies once treatment has started. If a separate doctor prescribes a new medicine during your targeted therapy course, tell both that doctor and your oncology team before you take the first dose.
Explore 119 more Targeted Therapy Basics, Testing & Your Cancer Type topics
Before You Start - Preparation & Baseline
- 25 Questions to Ask Your Oncologist Before Starting Targeted Therapy
- Before You Start Targeted Therapy: The Complete Preparation Checklist
- Dental Check-Up Before Cancer Treatment: Why It Matters
- Financial Planning Before Starting Long-Term Targeted Therapy
- How Long After Surgery Can You Start Targeted Therapy?
- How to Store Your Targeted Therapy Tablets Correctly
- Setting Up a Dosing Routine You Won't Forget
- Should Targeted Therapy Be Taken With Food or on an Empty Stomach?
- Vaccinations Before and During Cancer Treatment
- What to Expect in Your First Month on Targeted Therapy
- Which Baseline Tests Are Done Before Starting a TKI?
- Which of Your Existing Medicines Must Stop Before Targeted Therapy
- Why You Need an ECHO and ECG Before Certain Cancer Drugs
Biomarker & Molecular Testing
- Can Mutation Testing Be Done on an Old Biopsy Block or Slides?
- Cost of NGS and Mutation Testing in India: 2026 Price Guide
- Do I Need Genetic Testing Before Starting Targeted Therapy?
- Germline vs Somatic Testing: The Difference Nobody Explains Properly
- Getting a Second Opinion on Your Genomic Report
- How Long Do Mutation Test Results Take in India? Realistic Timelines
- How to Read Your Molecular Pathology Report, Line by Line
- IHC, FISH, PCR or NGS: Which Mutation Test Is Right for Your Cancer?
- Is Mutation Testing Worth It If I Can't Afford the Drug?
- Liquid Biopsy vs Tissue Biopsy: Which Test Do You Need?
- My Report Says a Mutation Is 'Actionable': What Does That Mean?
- No Mutation Found in My Report: What Are My Options Now?
- Should I Start Chemotherapy While Waiting for Mutation Results?
- Should You Repeat Molecular Testing After Your Cancer Progresses?
- Single-Gene Test or Full Panel? How to Choose Without Wasting Money
- What Are PD-L1, TMB and MSI, and Do They Affect Targeted Therapy?
- What Does 'Variant of Uncertain Significance' (VUS) Mean?
- What Happens If There Isn't Enough Tissue for Mutation Testing?
- What Is NGS (Next-Generation Sequencing) Testing in Cancer?
- What Is a Molecular Tumour Board and Why Should You Want One?
- Which Cancers Should Always Be Tested for Mutations? A Checklist
- ctDNA and MRD Testing: Tracking Cancer Through a Blood Test
Cancer-Type Specific Targeted Therapy
- CML Treatment with TKIs: Living a Normal Life Span
- Cancer of Unknown Primary: Can Molecular Testing Help?
- GIST Treatment: Why This Cancer Changed Targeted Therapy Forever
- Targeted Therapy for Bile Duct Cancer (Cholangiocarcinoma)
- Targeted Therapy for Bladder and Urothelial Cancer
- Targeted Therapy for Brain Tumours and Glioma
- Targeted Therapy for Breast Cancer: HER2, HR+ and Triple Negative
- Targeted Therapy for CLL and Lymphoma
- Targeted Therapy for Cervical and Endometrial Cancer
- Targeted Therapy for Childhood Cancers
- Targeted Therapy for Colorectal Cancer: RAS, BRAF and HER2
- Targeted Therapy for Head and Neck Cancer
- Targeted Therapy for Kidney Cancer (RCC)
- Targeted Therapy for Liver Cancer (HCC)
- Targeted Therapy for Lung Cancer: Every Mutation and Drug Explained
- Targeted Therapy for Melanoma: BRAF and MEK Inhibitors
- Targeted Therapy for Multiple Myeloma
- Targeted Therapy for Neuroendocrine Tumours
- Targeted Therapy for Ovarian Cancer: PARP Inhibitors and Beyond
- Targeted Therapy for Pancreatic Cancer: Limited but Real Options
- Targeted Therapy for Prostate Cancer
- Targeted Therapy for Sarcoma
- Targeted Therapy for Stomach and Gastroesophageal Cancer
- Targeted Therapy for Thyroid Cancer
- Targeted Therapy in AML: Beyond Standard Chemotherapy
- Tumour-Agnostic Drugs: When the Mutation Matters More Than the Organ
Foundations & How Targeted Therapy Works
- Adjuvant and Neoadjuvant Targeted Therapy: Treatment Before or After Surgery
- Antibody-Drug Conjugates (ADCs): The Smart Bombs of Cancer Treatment
- Biosimilars and Generic Targeted Therapy Drugs: What They Are
- Can Targeted Therapy Be Combined with Chemotherapy or Radiation?
- Can Targeted Therapy Cure Cancer? An Honest Answer
- First-Line, Second-Line and Beyond: How Treatment Lines Work
- How Doctors Decide Between Chemo, Immunotherapy and Targeted Therapy
- How Does Targeted Therapy Actually Work? Explained Without Jargon
- How Long Does Targeted Therapy Take to Start Working?
- Is Targeted Therapy Painful? What the Treatment Actually Feels Like
- Is Targeted Therapy a Type of Chemotherapy? Clearing Up the Confusion
- Oral Tablets vs IV Infusion Targeted Therapy: What's the Difference?
- Precision Oncology vs Personalised Medicine: Are They the Same Thing?
- Targeted Therapy Success Rates: What the Numbers Really Mean
- Targeted Therapy for Stage 4 Cancer: What You Can Realistically Expect
- Targeted Therapy vs Chemotherapy: 12 Differences That Actually Matter
- Targeted Therapy vs Immunotherapy: Which One Is Right for You?
- The 8 Main Types of Targeted Therapy Drugs (With Examples)
- What Do Cancer Drug Endings Like -nib, -mab and -tinib Mean?
- What Is Targeted Therapy for Cancer? A Complete Patient Guide
- Which Cancers Can Be Treated with Targeted Therapy? Full List
- Why Didn't My Doctor Recommend Targeted Therapy for Me?
Mutation & Target-Specific Pages
- ALK-Positive Lung Cancer: Drugs, Response and What Comes Next
- Antiangiogenic Drugs (VEGF Inhibitors): How Starving a Tumour Works
- BCR-ABL and the Philadelphia Chromosome in CML
- BRAF V600E Mutation: Targeted Therapy Across Multiple Cancers
- BRCA vs HRD Testing: Which One Determines PARP Inhibitor Eligibility?
- BRCA1 and BRCA2 Mutations in Cancer Treatment: PARP Inhibitors
- BTK Inhibitors in CLL and Lymphoma
- CD20, CD38 and Other Antibody Targets in Blood Cancers
- CDK4/6 Inhibitors in Hormone-Positive Breast Cancer
- Co-Mutations: When You Have Two Mutations at Once
- EGFR Exon 20 Insertion: Why It's Different and Harder to Treat
- EGFR Mutation in Lung Cancer: Complete Patient Guide
- ESR1 Mutation: Why Your Hormone Therapy Stopped Working
- FGFR Alterations in Bladder and Bile Duct Cancer
- FLT3 Mutation in AML: What It Means for Your Prognosis
- HER2 Mutation in Lung and Gastric Cancer
- HER2-Low Breast Cancer: A New Category That Changes Treatment
- HER2-Positive Breast Cancer: The Full Targeted Therapy Roadmap
- IDH1 and IDH2 Mutations in Glioma, AML and Bile Duct Cancer
- KIT and PDGFRA Mutations in GIST
- KRAS G12C Mutation: The Target That Was Undruggable for 40 Years
- KRAS Mutation but Not G12C: What Are My Options?
- MET Exon 14 Skipping and MET Amplification Explained
- MSI-High and Mismatch Repair Deficiency: Testing and Treatment
- NRG1, MET, RET and Other Rare Fusions: Where to Get Tested
- NTRK Fusion: One Drug for Many Different Cancers
- Osimertinib: What to Expect, Side Effects and How Long It Works
- PALB2, ATM and Other BRCA-Like Genes: Do They Get the Same Drugs?
- PIK3CA Mutation in Breast Cancer: Alpelisib and What to Expect
- PSMA and AR-Targeted Therapy in Prostate Cancer
- RET Fusion Cancer: Lung, Thyroid and Beyond
- ROS1-Positive Cancer: A Rare Mutation with Excellent Options
- TP53 Mutation: Why There's Still No Targeted Drug for It
- Understanding Variant Allele Frequency (VAF) in Your Report
- What If My Mutation Has No Approved Drug Yet?
- mTOR Inhibitors in Cancer: Everolimus and Temsirolimus
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Frequently asked questions
Will I have to stop my blood pressure or diabetes medicine?
Most people do not have to stop these medicines, but your team needs to review them because a small number of interactions exist between common long-term medicines and specific targeted drugs. Bring your full list and let your oncologist check rather than assuming either way. If a change is needed, your team will plan it carefully with whoever first prescribed that medicine so nothing is stopped abruptly.
Is St John's Wort really a problem — it is just a herbal supplement?
St John's Wort is one of the most clinically significant interactions known for targeted therapy. It activates the same liver enzyme that breaks down many targeted agents and can reduce the level of your drug in the blood to a point where treatment becomes less effective. NCCN and ESMO guidelines consistently list it as a medicine to stop before starting treatment. Being plant-derived does not make it safe to take alongside these drugs.
What about Ayurvedic or homeopathic preparations?
Tell your team about all of them, including anything you apply to the skin. This is not a judgement on those practices — it is because the ingredients in some preparations are not fully labelled, and certain plant compounds affect the same liver pathways as your targeted drug. Your team is not asking you to stop believing in them; they need to know what is in your system so they can make a safe plan.
What if the medicine I need to stop was prescribed by a different doctor?
Your oncologist will communicate with that doctor, or advise you on how to make the change safely. Never stop a medicine prescribed by another specialist on the basis of a list alone — both doctors need to agree on the plan. If your oncologist is uncertain whether an interaction is clinically significant for your specific targeted drug, they can consult the prescribing information or a clinical pharmacist.
How far in advance do I need to stop a medicine before targeted therapy starts?
There is no single answer — the timeline depends on both the medicine you are stopping and the targeted drug you are starting. This is one reason to bring your list to the appointment before your planned start date, so there is time to make any changes that are needed. Your oncologist will give you a specific instruction for each medicine once they have reviewed your full list.